Recon: FDA grants priority review to Sanofi’s hemophilia A drug; Pfizer invests $500M in decentralized drug development initiative

ReconReconBiologicsBiotechnologyDiagnosticsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy